Atlas Trials

Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers

Clinical trial NCT02749903 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02749903
Sponsor
Alliance for Clinical Trials in Oncology
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Salivary Cancer
Start date
2016-09-14
Primary completion
2019-02-21
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.